NEW YORK (GenomeWeb News) — PerkinElmer today said it plans to acquire privately held GPCR company Euroscreen Products for an undisclosed amount.
Euroscreen Products provides GPCR membranes, cell lines, and an aequorin-based cellular assay to drug makers.
PerkinElmer CEO Gregory Summe said the acquisition is the company’s “next step in our strategy to build the most comprehensive offering in cellular and drug discovery reagent technologies.”
By marketing Euroscreen Products’ AequoScreen platform in particular, Summe added, PerkinElmer would be able to offer its customers a “GPCR screening solution that improves performance and reduces workflow costs, while dramatically increasing lab productivity.”
PerkinElmer expects the acquisition to close some time during the first quarter of 2007.
Earlier this month PerkinElmer announced its plans to acquire high-throughput screening company Evotec Technologies for €23 million ($30.5 million) in cash.